tiprankstipranks
Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX
US Market
ELOX
Eloxx Pharmaceuticals
RESEARCH TOOLSreports

Eloxx Pharmaceuticals (ELOX) Income Statement

285 Followers

Eloxx Pharmaceuticals Income Statement

Last quarter (Q3 2023), Eloxx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Eloxx Pharmaceuticals's net income was $-3.59M. See Eloxx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 23Mar 22Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 6.44M$ 34.42M$ 66.02M$ 29.44M$ 50.55M
Depreciation and Amortization
$ 245.00K$ 695.00K$ 960.00K$ 571.00K$ 559.00K
EBITDA
$ -6.44M$ -31.75M$ -64.51M$ -32.60M$ -48.70M
Operating Income
$ -6.44M$ -34.42M$ -66.02M$ -33.45M$ -50.55M
Other Income/Expenses
$ 443.00K$ -1.65M$ -709.00K$ -1.12M$ -319.00K
Pretax Income
$ -6.00M$ -36.06M$ -66.73M$ -34.58M$ -50.87M
Net Income
$ -6.00M$ -36.06M$ -66.73M$ -34.58M$ -50.87M
Per Share Metrics
Basic EPS
$ -0.49$ -16.65$ -38.15$ -34.47$ -53.46
Diluted EPS
$ -0.49$ -16.65$ -38.15$ -34.47$ -53.46
Weighted Average Shares Outstanding
 12.35M 2.17M 1.75M 1.00M 951.58K
Weighted Average Shares Outstanding (Diluted)
 12.35M 2.17M 1.75M 1.00M 951.58K
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History